In an inpatient setting, how should uncontrolled withdrawal be treated with lorazepam (Ativan) PRN, including recommended dose and dosing frequency?

Lorazepam PRN for Uncontrolled Inpatient Withdrawal: Dosing and Frequency

For uncontrolled withdrawal in an inpatient setting, administer lorazepam 1-4 mg IV/IM/PO every 4-8 hours as needed, with lower starting doses (0.5-1 mg) for elderly or frail patients, and titrate based on withdrawal severity using objective assessment tools.

Initial Dosing Strategy

The appropriate lorazepam dose depends on the type of withdrawal and patient characteristics:

For Alcohol Withdrawal Syndrome (AWS)

• Standard adult dose: Start with lorazepam 1-4 mg PO/IV/IM every 4-8 hours PRN 1
• Elderly/debilitated patients: Reduce to 0.25-0.5 mg (maximum 2 mg in 24 hours) 2
• Standard patients: 0.5-1 mg orally four times daily PRN (maximum 4 mg in 24 hours) 2

For severe agitation or delirium in withdrawal, higher doses may be needed initially. In cancer patients with severe agitation, doses up to 1-2 mg SC/IV stat can be used, with lower doses (0.25-0.5 mg) for elderly/frail patients or those with COPD 3.

For Benzodiazepine Withdrawal

If the patient is withdrawing from chronic benzodiazepine use (iatrogenic or otherwise), do not use PRN dosing. Instead, convert to scheduled dosing to prevent withdrawal delirium 4:

1. Calculate the 24-hour midazolam equivalent dose if converting from IV midazolam
2. Divide by 12 to get daily lorazepam dose (accounting for lorazepam being twice as potent with sixfold longer half-life)
3. Divide by 4 and give every 6 hours as scheduled doses
4. Wean by 10-20% per day, gradually increasing dosing intervals (every 8h → 12h → 24h → every other day) 4

Critical Dosing Frequency Considerations

PRN dosing frequency should be every 1-4 hours for acute severe withdrawal, not the typical "every 4-8 hours" used for maintenance:

• For severe agitation/delirium: Every 1 hour PRN (up to 2 mg maximum per dose) 3
• For moderate withdrawal symptoms: Every 2-4 hours PRN 2
• For mild-moderate AWS: Every 4-8 hours PRN 1

When PRN Dosing Fails: Transition to Scheduled Regimen

If the patient requires lorazepam more than twice daily, transition from PRN to scheduled dosing 4. This is critical because:

• Frequent PRN use indicates inadequate baseline coverage
• Scheduled dosing prevents the peaks and troughs that worsen withdrawal symptoms
• It allows for systematic tapering rather than chaotic symptom-chasing

Calculate total lorazepam used in 24 hours, divide into scheduled doses (typically every 6-8 hours), then implement a gradual taper.

Essential Monitoring and Adjustments

Use objective withdrawal assessment tools (CIWA for alcohol, though not diagnostic 1) to guide dosing rather than relying solely on subjective complaints. Monitor for:

• Oversedation/respiratory depression - particularly critical with concurrent opioid use 5
• Paradoxical agitation - can occur, especially in younger patients 6
• Inadequate symptom control - requiring dose escalation or transition to scheduled dosing

Special Populations and Dose Modifications

Hepatic impairment: Lorazepam is preferred over other benzodiazepines because it undergoes glucuronidation (not hepatic oxidation), but still reduce doses 1

Renal impairment (eGFR <30): No specific dose reduction needed for lorazepam itself, but monitor closely 2

Elderly patients: Start at 0.25-0.5 mg and titrate cautiously; maximum 2 mg/24 hours 2, 3

Respiratory compromise: Use lower doses (0.5-1 mg) and monitor oxygen saturation closely 3

Critical Safety Warnings

The FDA label emphasizes that lorazepam carries significant risks 5:

• Respiratory depression is life-threatening when combined with opioids - monitor closely if concurrent use is unavoidable 5
• Abrupt discontinuation after frequent use (even if intended as PRN) can precipitate seizures and life-threatening withdrawal 5
• Tolerance develops rapidly - if using more frequently than recommended, physical dependence will occur 5

Common Pitfalls to Avoid

1. Using PRN lorazepam for benzodiazepine withdrawal - this worsens withdrawal symptoms; use scheduled tapering instead 7, 8
2. Linear dose reductions during tapering - produces escalating withdrawal effects; use hyperbolic/proportionate reductions (10-20% of current dose) 9
3. Inadequate final taper doses - may need doses as low as 0.2 mg diazepam equivalent; consider liquid formulations 9
4. Stopping assessment after initial dosing - withdrawal symptoms can be delayed, especially for benzodiazepine withdrawal 4
5. Ignoring the need for adjunctive therapy - thiamine 100-300 mg/day is mandatory for alcohol withdrawal 1

Alternative Considerations

If lorazepam PRN is insufficient despite appropriate dosing:

• Phenobarbital loading may reduce benzodiazepine requirements (20 mg/kg may be more effective than 10 mg/kg) 10
• Long-acting benzodiazepines (chlordiazepoxide, diazepam) are preferred for AWS prophylaxis but lorazepam is better for severe withdrawal, elderly, or hepatic impairment 1
• Antipsychotics (haloperidol 0.5-5 mg) for delirium symptoms, but only as adjunct, not monotherapy for withdrawal 1, 11